The Many Faces of Our Opioid Epidemic: Reducing Abuse While Promoting Appropriate Pain Management

Release Date: August 31, 2018
Expiration Date: August 31, 2019
Media: Internet - based

Activity Overview

As the staggering statistics regarding opioid-related overdoses and prescription misuse continue to climb, the opioid epidemic remains a concerning topic not only for members of a multidisciplinary healthcare team, but also for patients and caregivers as well. For this reason, interspersed with this panel discussion is the unique perspective of an individual who has witnessed multiple family members struggle with opioid misuse and abuse. The diverse background of the panel members will foster novel discussion on different aspects of providing pain management, including the progression and impact of the opioid health crisis, the role of quality measures and abuse-deterrent formulations, and the importance of collaborating with different members of the healthcare team.

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education™. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Target Audience

This CME activity is primarily intended for managed care professionals, including physicians and pharmacists.

Educational Objectives

Upon completion of this educational activity, participants will be able to:

  • Examine the challenges of balancing appropriate pain management while addressing the current opioid abuse epidemic
  • Explore strategies to prevent opioid misuse and abuse while maintaining legitimate pain control
  • Investigate a collaborative approach, highlighting the pharmacist’s and physician’s roles in addressing opioid misuse and abuse while promoting appropriate pain management

Faculty, Staff, and Planners' Disclosures


Winston Collins
Winston Collins, DSW, LCSW
Substance Use Programs
JFK Behavioral Health Center
Philadelphia, Pennsylvania
Precision Consultants of Philadelphia
Philadelphia, Pennsylvania

Disclosure: No relevant financial relationships with commercial interests to disclose.

Jeffrey Gudin
Jeffrey Gudin, MD
Pain Management and Palliative Care
Englewood Hospital and Medical Center
Englewood, New Jersey
Former Clinical Instructor, Anesthesiology
Icahn School of Medicine at Mount Sinai
Board Certified in Pain Management, Anesthesiology, Palliative Care, and Addiction Medicine

Disclosure: Consultant: BDSI, Daiichi Sankyo, Collegium, Kempharm, Mallinckrodt, Nektar, Pernix, Purdue; Speakers Bureau: AstraZeneca, DSI, Collegium, Purdue, Salix

Chris Herndon
Chris Herndon, PharmD, BCACP
School of Pharmacy
Southern Illinois University Edwardsville
Edwardsville, Illinois

Disclosure: No relevant financial relationships with commercial interests to disclose.

Peter Salgo
Peter Salgo, MD
Professor of Medicine and Anesthesiology
Columbia University College of Physicians and Surgeons
New York, New York

Disclosure: No relevant financial relationships with commercial interests to disclose.

Samuel Stolpe
Samuel Stolpe, PharmD, MPH
Principal and Consultant
Boston, Massachusetts

Disclosure: No relevant financial relationships with commercial interests to disclose.

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty member, and do not reflect those of PER® or the company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By